Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk Factors Associated with Recurrent Biliary Obstruction After Endoscopic Bilioduodenal Double Stenting.

Digestive diseases and sciences·2026
Same author

Marked Hyperbilirubinemia in a Patient with Intrahepatic Cholestasis of Pregnancy and a UGT1A1 Polymorphism: A Case Report.

Internal medicine (Tokyo, Japan)·2026
Same author

Effectiveness of Simulation-based Training on Emergency Response Knowledge Among Inter-Professional Staff Involved in Gastrointestinal Endoscopic Practice.

DEN open·2026
Same author

Comparison of the Clinical Outcomes Between Gel Immersion and Underwater Endoscopic Mucosal Resection for Superficial Non-ampullary Duodenal Epithelial Tumors (With Video).

DEN open·2026
Same author

Baseline and Longitudinal Liver Stiffness Measurement Predict Outcomes in Primary Biliary Cholangitis: A Multicenter Study.

Hepatology research : the official journal of the Japan Society of Hepatology·2026
Same author

Utility of pretreatment GLOBE score as a non-invasive prognostic tool in primary biliary cholangitis.

Immunological medicine·2026

Related Experiment Video

Updated: Jul 16, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Emerging Serological Biomarkers for Autoimmune Hepatitis.

Kazumichi Abe1, Jun Wada1, Hiromasa Ohira1

  • 1Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima City 960-1295, Japan.

Journal of Clinical Medicine
|July 15, 2026
PubMed
Summary

New autoantibodies, including anti-DOK2 and anti-MRPS27, show promise for diagnosing autoimmune hepatitis (AIH). Combined testing improves sensitivity for AIH detection, aiding clinical triage but not standalone confirmation.

Keywords:
autoantibodyautoimmune hepatitisdocking protein 2human protein microarraymitochondrial ribosomal protein S27

More Related Videos

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

Related Experiment Videos

Last Updated: Jul 16, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

Anti-Nuclear Antibody Screening Using HEp-2 Cells
13:01

Anti-Nuclear Antibody Screening Using HEp-2 Cells

Published on: June 23, 2014

Area of Science:

  • Immunology
  • Hepatology
  • Biomarker Discovery

Background:

  • Autoimmune hepatitis (AIH) lacks specific diagnostic biomarkers, especially in acute or seronegative cases.
  • High-throughput autoantibody profiling enables discovery of novel AIH-associated autoantigens.

Purpose of the Study:

  • To review emerging autoantibodies identified via proteome-wide screening for AIH diagnosis.
  • To evaluate the diagnostic potential of novel autoantibodies, particularly anti-DOK2 and anti-MRPS27.

Main Methods:

  • Proteome-wide screening approaches including human protein microarrays and phage immunoprecipitation sequencing.
  • Systematic discovery and validation of novel AIH-associated autoantibodies.

Main Results:

  • Emerging autoantibodies, specifically anti-docking protein 2 (DOK2) and anti-mitochondrial ribosomal protein S27 (MRPS27), demonstrate promising diagnostic performance.
  • Combined assessment of these autoantibodies significantly enhances diagnostic sensitivity for AIH.
  • While improving screening and triage, the reduced specificity limits their use as a standalone confirmatory test.

Conclusions:

  • Proteome-wide autoantibody discovery refines diagnostic strategies for AIH.
  • Integration of serological biomarkers with molecular pathology advances understanding of AIH pathogenesis.
  • Novel autoantibodies offer potential for improved AIH detection and patient management.